Engineered antibodies to combat viral threats

Nature, Published online: 18 November 2020; doi:10.1038/d41586-020-03196-2

As the COVID-19 pandemic rages globally, interest in antiviral treatments has never been higher. Antibodies are key defence components, and engineering them to better exploit their natural functions might boost therapeutic options.